Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001326732-26-000066·Zenas BioPharma, Inc.
Schedule 13G ownership disclosure
Zenas Biopharma Inc
Common Stock, par value $0.0001 per share · CUSIP: 98937L105
Event date: 2026-09-30
- Filing-level shares
- 1,000,000.00
- Percent of class
- 1.5%
- Xencor, Inc.
Shares: 1,000,000.00 · Class: 1.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001326732-26-000066
- Form type
- SCHEDULE 13G/A
- Filer
- Zenas BioPharma, Inc.
- CIK
- CIK 1953926
- Filed
- Nov 05, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership